John Somberg to Clinical Trials as Topic
This is a "connection" page, showing publications John Somberg has written about Clinical Trials as Topic.
Connection Strength
3.515
-
OUS results, clinical studies and therapeutic innovation in America. Am J Ther. 2014 Jul-Aug; 21(4):233.
Score: 0.436
-
Conflating the approval process and clinical research with pharmacoeconomic evaluation. Am J Ther. 2013 Jan; 20(1):1.
Score: 0.393
-
Is there an imperative for generic profiling to hasten the age of personalized medicine. Am J Ther. 2012 May; 19(3):163.
Score: 0.375
-
Drug and device trials: should we ask more. Am J Ther. 2011 Nov; 18(6):435.
Score: 0.363
-
Composite end points, black box warnings, and allegations of bias. Am J Ther. 2010 May-Jun; 17(3):233.
Score: 0.327
-
First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. Am J Ther. 2007 Nov-Dec; 14(6):594-604.
Score: 0.275
-
Drug trial registries. Am J Ther. 2004 Sep-Oct; 11(5):327.
Score: 0.221
-
Clinical trials registries. Am J Ther. 2003 Sep-Oct; 10(5):309-10.
Score: 0.206
-
What's gone wrong with clinical research. Am J Ther. 2000 Mar; 7(2):49-50.
Score: 0.162
-
New advances and new questions in cardiovascular therapeutics. Am J Ther. 2009 Sep-Oct; 16(5):375-7.
Score: 0.078
-
The extrapolation of study results in the device approval process. Am J Cardiol. 2009 May 01; 103(9):1323-4.
Score: 0.076
-
The sins of ghostwriting. Am J Ther. 2008 Jul-Aug; 15(4):297-8.
Score: 0.072
-
Mandatory post marketing studies. Am J Ther. 2007 Jul-Aug; 14(4):321.
Score: 0.067
-
Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment. Cardiology. 2006; 106(4):224-32.
Score: 0.062
-
Risk assessment, drug approval, and liability. Am J Ther. 2006 May-Jun; 13(3):181-2.
Score: 0.062
-
Chiral cardiovascular drugs: an overview. Am J Ther. 2005 Sep-Oct; 12(5):439-59.
Score: 0.059
-
Lessons learned from the COX-2 advisory hearings. Am J Ther. 2005 Mar-Apr; 12(2):105.
Score: 0.057
-
The pharmacologic treatment of heart failure. Am J Ther. 2004 Nov-Dec; 11(6):480-8.
Score: 0.056
-
Pediatric drug development. Am J Ther. 2003 Jan-Feb; 10(1):2.
Score: 0.049
-
Is the evidence right in evidence-based practice? Am J Ther. 2000 May; 7(3):149-50.
Score: 0.041
-
Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process. Am J Ther. 1999 May; 6(3):175-8.
Score: 0.038
-
Prophylactic tocainide or lidocaine in acute myocardial infarction. Am J Cardiol. 1986 Mar 01; 57(8):527-31.
Score: 0.015
-
Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90.
Score: 0.014
-
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8.
Score: 0.004
-
Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol. 1986 Oct; 8(4):752-62.
Score: 0.004
-
Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
Score: 0.004